The Biomarkers Consortium is Requesting for Proposals (RFP) for Developing Endpoints for Clinical Trials of Drugs for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

RFP Objective: Solicit applications from organizations with experience in developing well-defined and reliable clinical trial outcome assessments

Issued by: The Foundation for the National Institutes of Health Biomarkers Consortium (FNIH BC) on January 09, 2012

Responses: must be received by 11:59 PM ET on February 06, 2012

Award will be announced by FNIH: on or before April 02, 2012

Eligibility: Any organization from the private and public sector is eligible to apply as long as it can meet the requirements below. It is acceptable for more than one organization to collaborate and submit a joint response.

CLICK HERE FOR THE RFP >>